Skip to main content
What actually is Medicare and Medicaid fraud?
To:Brew Readers
Though it’s a hot topic that fraud runs rampant, experts say the actual data doesn’t align.

We have some exciting news for you. Detailed data is out for Revolution Medicine’s new cancer drug, daraxonrasib, and it’s so good that it literally got a standing ovation at the annual American Society of Clinical Oncology conference, per multiple news outlets. The company shared in an April press release that its drug nearly doubled survival compared to chemotherapy for people with advanced pancreatic cancer in a Phase 3 clinical trial, and this release of more detailed data backs that up.

In today’s edition:

Fact-checking federal payer fraud

🪗 Hospitals feel ACA squeeze

May’s hospital M&A

—Maia Anderson, Cassie McGrath, Caroline Catherman

         
ADVERTISE // CAREERS // SHOP // FAQ

Update your email preferences or unsubscribe here.
View our privacy policy here.

Copyright © 2026 Morning Brew Inc. All rights reserved.
22 W 19th St, 4th Floor, New York, NY 10011

Navigate the healthcare industry

Healthcare Brew covers pharmaceutical developments, health startups, the latest tech, and how it impacts hospitals and providers to keep administrators and providers informed.

By subscribing, you accept our Terms & Privacy Policy.

A mobile phone scrolling a newsletter issue of Healthcare Brew